Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Volume 16 Supplement 2

Proceedings of the 3rd International Genomic Medicine Conference: cancer

Proceedings

Publication of this supplement has been supported by the Centre of Excellence in Genomic Medicine Research. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editor declares that they have no competing interests.

Jeddah, Saudi Arabia30 November - 3 December 2015

Edited by Muhammad Abu-Elmagd.

  1. Content type: Research article

    Renal cell carcinoma (RCC) is a seventh ranked malignancy with poor prognosis. RCC is lethal at metastatic stage as it does not respond to conventional systemic treatments, and there is an urgent need to find ...

    Authors: Sajjad Karim, Jaudah A. Al-Maghrabi, Hasan M. A. Farsi, Ahmad J. Al-Sayyad, Hans-Juergen Schulten, Abdelbaset Buhmeida, Zeenat Mirza, Alaa A. Al-boogmi, Fai T. Ashgan, Manal M. Shabaad, Hend F. NourEldin, Khalid B. M. Al-Ghamdi, Adel Abuzenadah, Adeel G. A. Chaudhary and Mohammed H. Al-Qahtani

    Citation: BMC Cancer 2016 16(Suppl 2):741

    Published on:

  2. Content type: Review

    Cancer cells, stem cells and cancer stem cells have for a long time played a significant role in the biomedical sciences. Though cancer therapy is more effective than it was a few years ago, the truth is that ...

    Authors: Sara S. Franco, Karolina Szczesna, Maria S. Iliou, Mohammed Al-Qahtani, Ali Mobasheri, Julianna Kobolák and András Dinnyés

    Citation: BMC Cancer 2016 16(Suppl 2):738

    Published on: